Evaluation of the Efficacy of STERIFY GEL in the Treatment of Periodontitis Following Scaling and Root Planing
SFYCT
Evaluation of the Efficacy and Safety of STERIFY GEL in the Treatment of Periodontitis Following Scaling and Root Planing: Pivotal, Prospective, Single-center, Split-mouth, Randomized, Controlled Study
1 other identifier
interventional
34
1 country
1
Brief Summary
The purpose of this clinical study is to evaluate the safety and efficacy of treating periodontal disease with the STERIFY GEL medical device in combination with SRP procedure, in terms of periodontal pocket healing. Efficacy will be compared with the use of the nonsurgical SRP technique alone, which is considered a gold standard treatment for periodontitis, with the aim of observing improved results when using the STERIFY GEL device. The study is prospective, split-mouth.STERIFY GEL will be administered into the periodontal pockets of one or two segments of patients undergoing whole-mouth extended SRP, with the contralateral segments serving as controls (split-mouth), in a single session.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 6, 2023
CompletedFirst Submitted
Initial submission to the registry
July 26, 2023
CompletedFirst Posted
Study publicly available on registry
August 3, 2023
CompletedAugust 7, 2023
August 1, 2023
3 months
July 26, 2023
August 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pocket Depth
Measurement by periodontal probe of periodontal pocket depth. Unit of measurement in mm with a sensitivity of 0.5 mm.
Pre-treatment, 1 month, 2 months, 3 months
Secondary Outcomes (7)
Gingival recession
Pre-treatment, 1 month, 2 months, 3 months
Clinical Attachment Level
Pre-treatment, 1 month, 2 months, 3 months
Plaque Index
Pre-treatment, 1 month, 2 months, 3 months
Bleeding Index
Pre-treatment, 1 month, 2 months, 3 months
Furcations
Pre-treatment, 1 month, 2 months, 3 months
- +2 more secondary outcomes
Study Arms (2)
Sterify Gel + SRP
EXPERIMENTALScaling and root planing in the assigned site, followed by intra-pocket administration of Sterify Gel, applied to the bottom of the pocket until the gel emerges or becomes visible at the gingival margin
SRP only
ACTIVE COMPARATORScaling and root planing in the assigned site.
Interventions
A mucoadhesive polymeric hydrogel in a prefilled syringe for nonsurgical treatment of periodontal and peri-implant pockets, composed of polyvinyl polymers, hydroxytyrosol, nisin, and magnesium ascorbyl phosphate
The non-surgical procedure involved SRP under local anesthesia with EMS scalers and Gracey curettes.
Eligibility Criteria
You may qualify if:
- Patients with grade III and IV chronic periodontal disease according to the European Federation of Periodontology classification involving at least two sites
- Adherence to the study and signing of informed consent
- Major age- Participants with a minimum of 6 teeth with periodontal pocket depth greater than 5mm- Participants with at least 20 teeth
You may not qualify if:
- Established hypersensitivity to one or more components of the device- Pregnancy or lactation- Heavy smoker (more than 9 cigarettes per day)- Concomitant dental disease, except periodontitis, or planned treatment that may interfere with the study or study procedure, such as dental surgery or tooth implantation- Diabetes mellitus, rheumatoid arthritis, or other chronic diseases that may affect disease or treatment
- Aggressive periodontitis
- History of radiation or chemotherapy
- Autoimmune mucosal diseases
- Mental illnesses
- Parafunctions such as bruxism
- Use of antibiotics in the past 3 months
- Periodontal surgeries in the past 12 months in the areas covered by the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sterify S.r.l.lead
- Sciently di Omar Sabrycollaborator
Study Sites (1)
Odontostomatologia, ASST dei Sette Laghi
Varese, 21100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2023
First Posted
August 3, 2023
Study Start
December 3, 2022
Primary Completion
March 11, 2023
Study Completion
April 6, 2023
Last Updated
August 7, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share